New York — drug testing employment law

At a glance: New York

Overview: drug testing in New York

New York's Marijuana Regulation and Taxation Act (MRTA, 2021) legalized adult-use cannabis. Crucially, MRTA amended N.Y. Labor Law § 201-d, the state's longstanding lawful-recreational-activity statute, to include cannabis. The result is one of the most worker-protective off-duty cannabis frameworks in the country.

Cannabis law and workplace testing

Labor Law § 201-d prohibits New York employers from refusing to hire, employ, or license, or from discharging or otherwise discriminating against an individual because of off-duty cannabis use. Exceptions exist for federal-contractor, DOT-regulated, and certain other federally affected roles, and employers retain rights to act on workplace impairment. New York State Department of Labor guidance interprets § 201-d narrowly favorable to employees.

Specific testing rules in New York

The table below summarizes how New York typically treats four common workplace testing scenarios. Each row reflects the dominant statutory or case-law position; carve-outs (federal-contractor, DOT-regulated, safety-sensitive, etc.) may shift any individual analysis.

Federal overlay: DOT and federal contractors

In all U.S. states — including New York — DOT-regulated employees (safety-sensitive roles in transportation industries under 49 CFR Part 40) and federal-contractor employees subject to the federal Drug-Free Workplace Act of 1988 are testable under federal rules regardless of state cannabis status or workplace-testing restrictions. State law cannot reduce federal testing obligations for these populations. Where state law otherwise restricts cannabis testing, the federal-overlay carve-out typically preserves the employer's authority for these federally affected roles.

For employers in New York

New York employers should not test for cannabis as part of pre-employment screening except for statutorily exempt roles. Reasonable-suspicion testing remains permissible. Define and document safety-sensitive role exemptions. Federal-contractor and DOT roles remain testable per federal law.

• Written policy. Document the substances tested, the cutoff levels, the testing modalities (urine / oral fluid / hair), and the consequences of a non-negative result.
• Notice. Provide written notice before testing begins and obtain signed acknowledgement where the state requires it.
• Certified laboratory. Use a SAMHSA-certified or equivalent laboratory; document chain of custody.
• Confirmation testing. Confirm any non-negative initial result with mass-spectrometry (GC-MS or LC-MS/MS) before any adverse action.
• MRO review. Engage a qualified Medical Review Officer to review all non-negative results before reporting to the employer.
• Safety-sensitive designations. If the role is statutorily exempt as safety-sensitive, document the designation in writing using the state\'s statutory definition.
• Medical cannabis disclosures. Where state law provides patient protection, engage an interactive accommodation process before adverse action.

For workers in New York

New York provides one of the strongest off-duty cannabis protections in the country. Off-duty use cannot be the sole basis for adverse action in non-exempt roles. Medical cannabis patients have additional anti-discrimination protection.

• Know the policy. Request a copy of your employer\'s written testing policy — it should specify when testing occurs, what is tested, and how to challenge a result.
• Disclose medications to the MRO, not the employer. The Medical Review Officer reviews non-negative results before they are reported and can resolve a legitimate prescription explanation.
• Document medical cannabis status. If you are a registered medical cannabis patient in a state with patient protection, document your status with HR before testing.
• Confirmation testing. Any non-negative initial result should be confirmed by GC-MS or LC-MS/MS before adverse action.
• Appeal rights. Many state statutes provide an appeals process — read your employer\'s policy carefully.

Key statutes and citations

The following statutory citations are the primary controlling authority for drug testing employment law in New York. We provide citations only — confirm current text via your state legislature\'s codified statutes (or an authoritative legal research platform) before relying on this information.

• Marijuana Regulation and Taxation Act (MRTA) — N.Y. Cannabis Law § 1 et seq.
• Lawful Recreational Activity / Off-duty Conduct — N.Y. Lab. Law § 201-d
• Compassionate Care Act — N.Y. Pub. Health Law § 3360 et seq.

Multi-state employers operating in New York

A national or multi-state employer\'s policy that works in a permissive state (e.g., Alabama or Texas) may not be lawful as applied to employees in New York, and vice versa. Common multi-state pitfalls include: applying a national pre-employment cannabis screen in jurisdictions that prohibit it; treating a positive cannabis test as automatic disqualification where state law restricts that outcome; failing to designate safety-sensitive roles in compliance with the relevant state\'s statutory definition; and not maintaining state-specific written policies and acknowledgements. For multi-state programs, see our multi-state employer guide.

How this page is built and reviewed

This page combines a structured data layer (cannabis status, statutory protection levels, voluntary program details, statute citations) with state-specific narrative drafted from primary statutes and authoritative secondary sources. Every claim should trace either to a statute citation, an authoritative secondary source (e.g., NCSL, EEOC, DOT, SHRM, ASAM), or general background knowledge clearly framed as such. The page is reviewed against the listed sources on each material amendment.

Found something out of date? Let us know — we update state pages as statutes and case law evolve.